Ki67 increase after core needle biopsy associated with worse disease outcome in her2-negative breast cancer patients

HIGHLIGHTS

• who: Yiwei Tong from the DepartmentUniversity School have published the research work: Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patients, in the Journal: Scientific Reports Scientific Reports
• what: CNB is an important manner to ensure a diagnosis of breast cancer and also evaluate ER, PR, HER2, and Ki67 status before the initiation of breast cancer treatment.

SUMMARY

Breast cancer molecular subtype was determined by using the 2013 St. Gallen ­consensus14: Luminal A (Hormonal receptor+/HER2-, Ki67 and amp;lt; 20%), Luminal B . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.